Host adaptation and convergent evolution increases antibiotic resistance without loss of virulence in a major human pathogen

PLoS Pathog. 2019 Mar 15;15(3):e1007218. doi: 10.1371/journal.ppat.1007218. eCollection 2019 Mar.

Abstract

As human population density and antibiotic exposure increase, specialised bacterial subtypes have begun to emerge. Arising among species that are common commensals and infrequent pathogens, antibiotic-resistant 'high-risk clones' have evolved to better survive in the modern human. Here, we show that the major matrix porin (OmpK35) of Klebsiella pneumoniae is not required in the mammalian host for colonisation, pathogenesis, nor for antibiotic resistance, and that it is commonly absent in pathogenic isolates. This is found in association with, but apparently independent of, a highly specific change in the co-regulated partner porin, the osmoporin (OmpK36), which provides enhanced antibiotic resistance without significant loss of fitness in the mammalian host. These features are common in well-described 'high-risk clones' of K. pneumoniae, as well as in unrelated members of this species and similar adaptations are found in other members of the Enterobacteriaceae that share this lifestyle. Available sequence data indicate evolutionary convergence, with implications for the spread of lethal antibiotic-resistant pathogens in humans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism
  • Bacterial Proteins / physiology*
  • Drug Resistance, Bacterial / genetics*
  • Drug Resistance, Bacterial / physiology
  • Drug Resistance, Microbial
  • Humans
  • Klebsiella Infections / genetics
  • Klebsiella Infections / metabolism
  • Klebsiella pneumoniae / genetics
  • Klebsiella pneumoniae / pathogenicity
  • Microbial Sensitivity Tests
  • Porins / genetics
  • Porins / metabolism
  • Porins / physiology*
  • Virulence
  • beta-Lactam Resistance / genetics*
  • beta-Lactam Resistance / physiology
  • beta-Lactamases / pharmacology

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • OmpK35 porin, Klebsiella pneumoniae
  • OmpK36 protein, Klebsiella pneumoniae
  • Porins
  • beta-Lactamases

Grants and funding

This work, including the efforts of all the authors was funded by Department of Health, National Health and Medical Research Council (NHMRC) (G1046886 and G1104232). This work, including the efforts of Alex Agyekum, was funded by Ghana Education Trust Fund (GETFUND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.